This is plumb normal for all biotechs that dose first patient. It is classified as PS.
its like quarterlies for pre revenue companies. They're mostly all known info but marked as PS.
- Forums
- ASX - By Stock
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
3.24%
!
$2.23

This is plumb normal for all biotechs that dose first patient....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.23 |
Change
0.070(3.24%) |
Mkt cap ! $716.6M |
Open | High | Low | Value | Volume |
$2.15 | $2.29 | $2.13 | $4.198M | 1.899M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4477 | $2.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.23 | 9998 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4477 | 2.220 |
2 | 5414 | 2.210 |
6 | 54930 | 2.200 |
2 | 27656 | 2.190 |
4 | 29371 | 2.180 |
Price($) | Vol. | No. |
---|---|---|
2.230 | 9998 | 1 |
2.240 | 28473 | 1 |
2.250 | 20789 | 6 |
2.260 | 392 | 1 |
2.270 | 16820 | 1 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |